Healthcare provider profile · identity verified

Francisco Eugenio Rodriguez, MD

Internal Medicine · AGUADILLA, PR · NPI 1609982792

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	652	176
Famotidine	Famotidine	577	142
Pantoprazole Sodium	Pantoprazole Sodium	485	105
Amlodipine Besylate	Amlodipine Besylate	422	120
Simvastatin	Simvastatin	411	121
Gabapentin	Gabapentin	395	95
Farxiga	Dapagliflozin Propanediol	356	64
Atorvastatin Calcium	Atorvastatin Calcium	349	105
Rosuvastatin Calcium	Rosuvastatin Calcium	323	95
Metformin Hcl	Metformin Hcl	318	90
Alendronate Sodium	Alendronate Sodium	270	81
Lantus	Insulin Glargine,hum.Rec.Anlog	230	42
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	221	34
Sulindac	Sulindac	189	49
Fluoxetine Hcl	Fluoxetine Hcl	182	58
Metoprolol Succinate	Metoprolol Succinate	179	52
Levothyroxine Sodium	Levothyroxine Sodium	167	48
Clopidogrel	Clopidogrel Bisulfate	161	40
Escitalopram Oxalate	Escitalopram Oxalate	156	34
Sertraline Hcl	Sertraline Hcl	156	41
Synthroid	Levothyroxine Sodium	154	36
Carvedilol	Carvedilol	152	45
Metoprolol Tartrate	Metoprolol Tartrate	144	44
Pioglitazone Hcl	Pioglitazone Hcl	144	37
Ezetimibe	Ezetimibe	131	42
Glimepiride	Glimepiride	117	32
Omeprazole	Omeprazole	113	28
Prednisone	Prednisone	105	74
Montelukast Sodium	Montelukast Sodium	101	29
Lorazepam	Lorazepam	95	15
Albuterol Sulfate Hfa	Albuterol Sulfate	93	22
Clonazepam	Clonazepam	92	15
Lansoprazole	Lansoprazole	91	16
Spironolactone	Spironolactone	91	26
Lisinopril	Lisinopril	80	27
Tamsulosin Hcl	Tamsulosin Hcl	80	24
Trazodone Hcl	Trazodone Hcl	76	19
Alprazolam	Alprazolam	75	suppressed
Buspirone Hcl	Buspirone Hcl	74	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	21
Meloxicam	Meloxicam	70	18
Methotrexate	Methotrexate Sodium	69	11
Estazolam	Estazolam	67	11
Doxazosin Mesylate	Doxazosin Mesylate	60	19
Duloxetine Hcl	Duloxetine Hcl	58	17
Hydrochlorothiazide	Hydrochlorothiazide	55	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	54	20
Enalapril Maleate	Enalapril Maleate	53	14
Lactulose	Lactulose	51	14
Latanoprost	Latanoprost	49	suppressed
Temazepam	Temazepam	48	suppressed
Clonidine Hcl	Clonidine Hcl	47	16
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	46	12
Enulose	Lactulose	45	12
Pregabalin	Pregabalin	45	suppressed
Raloxifene Hcl	Raloxifene Hcl	44	suppressed
Nabumetone	Nabumetone	43	13
Dexamethasone	Dexamethasone	41	38
Divalproex Sodium	Divalproex Sodium	41	suppressed
Insulin Glargine	Insulin Glargine,hum.Rec.Anlog	38	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	37	25
Tolterodine Tartrate Er	Tolterodine Tartrate	37	suppressed
Irbesartan	Irbesartan	36	15
Olmesartan Medoxomil	Olmesartan Medoxomil	36	11
Naproxen	Naproxen	34	12
Furosemide	Furosemide	33	suppressed
Azithromycin	Azithromycin	31	29
Bumetanide	Bumetanide	31	suppressed
Ketoconazole	Ketoconazole	31	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Eliquis	Apixaban	30	12
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	15
Allopurinol	Allopurinol	28	suppressed
Insulin Lispro	Insulin Lispro	28	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	27	suppressed
Atenolol	Atenolol	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Tramadol Hcl	Tramadol Hcl	23	15
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Levofloxacin	Levofloxacin	20	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	16
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Diclofenac Potassium	Diclofenac Potassium	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Fluconazole	Fluconazole	19	16
Diazepam	Diazepam	18	16
Leflunomide	Leflunomide	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Risperidone	Risperidone	17	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	17	suppressed
Valsartan	Valsartan	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Jentadueto	Linagliptin/Metformin Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Ramipril	Ramipril	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error